SCHEMBL6529618

SCHEMBL6529618

COC(=O)CNc1nc(Cc2ccc(OC)cc2)nc(Nc2cccc(F)c2)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH3 Q9ULD8 4/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
ALDH1A1 P00352 2/20 0.44
POLB P06746 2/20 0.44
CA12 O43570 3/20 0.43
CA1 P00915 3/20 0.43
CA2 P00918 3/20 0.43
CA9 Q16790 3/20 0.43
CA14 Q9ULX7 3/20 0.43
EGFR P00533 1/20 0.43
JAK3 P52333 1/20 0.43
BTK Q06187 1/20 0.43
HPGD P15428 1/20 0.43
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MAPT P10636 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6530549 0.85 MAPT (0.54) KCNH3MEN1KMT2AALDH1A1POLB
SCHEMBL6531533 0.83 CA12 (0.45) KCNH3MEN1KMT2AALDH1A1POLB
SCHEMBL8298690 0.81 APP (0.54) KCNH3MEN1KMT2AALDH1A1POLB
SCHEMBL8298689 0.80 CYP2C9 (0.44) KCNH3ALDH1A1EGFRJAK3BTK
SCHEMBL6528805 0.80 CYP2C9 (0.44) KCNH3ALDH1A1EGFRJAK3BTK
SCHEMBL6531320 0.77 ALDH1A1 (0.45) KCNH3ALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL9779973 0.72 MEN1 (0.53) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL8021371 0.71 SAE1 (0.51) CA12CA1CA2CA9MAPT
SCHEMBL6530247 0.71 ALDH1A1 (0.47) KCNH3ALDH1A1CA12CA1CA2
SCHEMBL6530423 0.71 ALDH1A1 (0.47) KCNH3ALDH1A1CYP1A2CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO claimed
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO disclosed